SEATTLE, WASHINGTON--(Marketwire - May 25, 2012) - VentriPoint Diagnostics Ltd. (TSXV:VPT) (VPTDF) has installed its VMS(TM) heart analysis system at University Children's Hospital in Zurich, Switzerland for their Congenital Heart Disease clinics.
"With the implementation of VMS(TM), we complete the spectrum of imaging modalities that we can offer to our patients. We will use the system in patients with repaired Tetralogy of Fallot, a population in which our group has a longstanding and successful experience, both in clinical practice and advancing technology through research. We will expand the clinical use of VMS(TM) for evaluation of patients with transposition of the great arteries and atrial repair, through the involvement of our adult congenital heart disease clinic. VMS(TM) will save us time and effort in managing our congenital heart disease patients," stated Dr. Emanuela Valsangiacomo-Buchel, Cardiologist at the University Children's Hospital.
The division of Pediatric Cardiology at University Children's Hospital in Zurich is the largest division in Switzerland taking care of Children with CHD, and provides the entire spectrum of subspecialties in the field.
"With VMS(TM) heart analysis systems in the United Kingdom, Norway, Netherlands and now Switzerland, we are rapidly building a network of reference centres in Europe where interested cardiologists can go to use the VMS(TM) prior to acquiring one for their own hospitals", said Dr. George Adams, CEO of VentriPoint.
The VMS(TM) is for investigational use only in the United States and is approved for sale and clinical use in Canada and Europe.
About VentriPoint Diagnostics Ltd.
VentriPoint has created a diagnostic ultrasound tool to monitor patients with heart disease, a leading cause of death in developed countries. Management believes the VMS(TM) is the first cost-effective and accurate diagnostic tool for measuring right ventricle heart function. Congenital heart disease is the first application in a suite of applications for all major heart diseases including pulmonary hypertension, cardiovascular disease and heart failure, which management believes has a multibillion-dollar market potential. Canada and Europe (CE Mark) have granted approval for the sale of VentriPoint's VMS(TM) heart analysis system and VentriPoint is pursuing the US-FDA approval through the 510(k) process.
FORWARD-LOOKING STATEMENTS: The statements made in this press release that are not historical facts contain forward-looking information that involves risk and uncertainties. All statements, other than statements of historical facts, which address VentriPoint's expectations, should be considered forward-looking statements. Such statements are based on management's exercise of business judgment as well as assumptions made by and information currently available to management. When used in this document, the words "may", "will", "anticipate", "believe", "estimate", "expect", "intend" and words of similar import, are intended to identify any forward-looking statements. You should not place undue reliance on these forward-looking statements. These statements reflect a current view of future events and are subject to certain risks and uncertainties as contained in the Corporation's filings with Canadian securities regulatory authorities. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results could differ materially from those anticipated in these forward-looking statements. These forward-looking statements are made as of the date of this press release and, other than as required by applicable securities laws, the Corporation does not assume any obligation to update or revise them to reflect new events or circumstances. Although management believes that expectations are based on reasonable assumptions, no assurance can be given that these expectations will materialize.Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release
|06:00 AM||BMO Banque privée : Les investisseurs devraient-ils adopter l'adage "Sell in May and Go Away" comme stratégie?|
|06:00 AM||AlterGo exprime des recommandations concernant l'accessibilité universelle de la Ville de Montréal|
|06:00 AM||RAPPEL/Avis aux médias : Le ministre Oliver fera la promotion des avantages économique du développement responsable des ressources naturelles|
|06:00 AM||Bayfield Drills 16.0m of 10.47 g/t Gold and 34.68 g/t Silver on Intrepid Zone in Rainy River, NW Ontario|
|05:00 AM||FrogTape(R) Launches New Website With Updated Design and Social Media Sharing Tools|
|12:01 AM||AMD Amplifies Mobile Experience With Responsive Performance, Rich Graphics, Elite Software and Long Battery Life|
|Wed, May 22, 2013|
|10:40 PM||Goldeye Sets New Meeting Date to Update By-laws, Adopt New Stock Option Plan, and Re-Affirm Shareholder Rights Plan|
|10:02 PM||Mise à jour-Danger pour la santé : Présence possible de la bactérie Salmonella dans certaines avelines (noisettes) en écales ou noix mélangées en écales|
|08:47 PM||Sangoma Reports Results for Third Quarter of Fiscal 2013|
|07:38 PM||Ivanhoe Australia Limited: Proposed Company Name Change to Inova Resources Limited|
|07:02 PM||Calibre Mining Corp. Announces Results of Annual General and Special Meeting|
|07:00 PM||Kariana Resources Inc. Appoints New CEO and Director|
|06:00 PM||Canadian Orebodies Announces Adoption of Advance Notice By-Law|
|05:37 PM||Energy Income Fund Appoints Vestcap Investment Management as Investment Manager|
|05:16 PM||Vanoil Acquires Fluormin Plc.|
|05:01 PM||VIQ Solutions Reports First Quarter 2013 Results|
|05:00 PM||Functional Technologies to Apply for Extension of Creditor Protection Period|
|04:49 PM||Avis aux médias : Le ministre de l'Industrie prononcera une allocution lors d'un événement organisé par Aéro Montréal|
|04:49 PM||Media Advisory: Minister of Industry to Speak at Aero Montreal Event|
|04:44 PM||Pro-Trans Ventures Inc. Announces Resignation of Its President and CEO|
|04:44 PM||Spur Announces Adoption of Advance Notice Policy for Future Shareholder Meetings|
|04:39 PM||Total Energy Services Inc. Reports on Voting from the 2013 Annual and Special Meeting of Shareholders|
|04:38 PM||Exploration Khalkos inc. : Réorientation de la mission corporative sur des projets plus avancés|
|04:38 PM||Khalkos Exploration Inc.: Corporation Mission Shifts Towards More Advanced Projects|
|04:10 PM||IIROC: Resume, Cornerstone Metals Inc.|
|04:03 PM||2013-0507 - Suspension - Ecosse Energy Corp. (ECS)|
|04:03 PM||Leader Energy Services Reports First Quarter 2013 Results|
|04:01 PM||Macro Enterprises Inc. Announces 2013 First Quarter Results and Appointment of Independent Director|
|04:00 PM||Reliant Gold Corp. Announces Filing of Condensed Interim Financial Statements as at and for the Three Months Ended March 31, 2013 and Related Management's Discussion and Analysis|
|03:44 PM||La nouvelle carte électorale fédérale de l'Alberta|
|More Press Releases From Marketwired|